Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Capital Expenditures (2016 - 2025)

Orthofix Medical's Capital Expenditures history spans 16 years, with the latest figure at $10.9 million for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures rose 27.5% year-over-year to $10.9 million, compared with a TTM value of $34.6 million through Dec 2025, down 0.72%, and an annual FY2025 reading of $34.6 million, down 0.72% over the prior year.
  • Capital Expenditures for Q4 2025 was $10.9 million at Orthofix Medical, up from $9.9 million in the prior quarter.
  • The five-year high for Capital Expenditures was $21.9 million in Q3 2023, with the low at $2.5 million in Q3 2021.
  • Average Capital Expenditures over 5 years is $8.6 million, with a median of $7.1 million recorded in 2022.
  • Year-over-year, Capital Expenditures skyrocketed 326.6% in 2023 and then plummeted 73.43% in 2024.
  • Tracing OFIX's Capital Expenditures over 5 years: stood at $6.2 million in 2021, then increased by 12.47% to $7.0 million in 2022, then soared by 133.61% to $16.4 million in 2023, then plummeted by 47.84% to $8.5 million in 2024, then rose by 27.5% to $10.9 million in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Capital Expenditures are $10.9 million (Q4 2025), $9.9 million (Q3 2025), and $7.1 million (Q2 2025).